Chlorhexidine Mouthrinse (n = 51) | Usual Care (n = 55) | P Value | |
---|---|---|---|
Indication for EBUS-TBNA | > 0.99 | ||
Diagnosis or staging of malignancy | 49 (96.1) | 52 (94.5) | |
Diagnosis of benign disease | 2 (3.9) | 3 (5.5) | |
Conventional bronchoscopy | 42 (82.4) | 49 (89.1) | 0.32 |
Bronchial washing | 6 (11.8) | 5 (9.1) | 0.65 |
Bronchoalveolar lavage | 0 (0.0) | 1 (1.8) | > 0.99 |
Endobronchial biopsy | 8 (15.7) | 3 (5.5) | 0.08 |
EUS-B-FNA | 4 (7.8) | 5 (9.1) | > 0.99 |
Number of insertions of EBUS bronchoscope | 0.50 | ||
≤ 1 | 45 (88.2) | 46 (83.6) | |
> 1 | 6 (11.8) | 9 (16.4) | |
Number of aspiration needles used per patient | 0.28 | ||
≤ 1 | 44 (86.3) | 51 (92.7) | |
> 1 | 7 (13.7) | 4 (7.3) | |
Number of LNs punctured per patient | 0.91 | ||
≤ 3 | 31 (60.8) | 34 (61.8) | |
> 3 | 20 (39.2) | 21 (38.2) | |
Total number of aspirations per patient | 0.89 | ||
≤ 5 | 29 (56.9) | 32 (58.2) | |
> 5 | 22 (43.1) | 23 (41.8) | |
Characteristics of LNs/masses | |||
Heterogeneous echogenicity on ultrasound | 22 (43.1) | 16 (29.1) | 0.13 |
Coagulation necrosis sign on ultrasound or aspirates with pus-like material | 10 (19.6) | 3 (5.5) | 0.03 |
Procedure time | |||
Conventional bronchoscopy, min | 3 (2–6) | 3 (2–5) | 0.56 |
EBUS-TBNA, min | 19 (9–30) | 20 (14–31) | 0.37 |
Dosage of sedatives | |||
Midazolam, mg | 4 (3–5) | 5 (3–5) | 0.37 |
Fentanyl, μg | 50 (50–50) | 50 (50–50) | 0.49 |
Antibiotic prophylaxis after EBUS-TBNA | 19 (37.3) | 19 (34.5) | 0.77 |